BioStem Technologies, Inc.
New Form D on file · 2026-09-21 · the record
What the record says
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 759 filings in Biotechnology, totalled by week.
Company officers on record
Jason Matuszewski is named as Executive Officer and Director on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Brandon Poe is named as Executive Officer on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Andrew Van Vurst is named as Executive Officer and Director on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Barry Hassett is named as Executive Officer on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Katherine Gorrell is named as Executive Officer on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Kenneth Warrington is named as Director on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Mark Glickman is named as Director on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Rayna Lesser Hannaway is named as Director on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Jodi Ungrodt is named as Director on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
Steven Sonenreich is named as Director on the Form D that BioStem Technologies, Inc. filed with the SEC on 21 September 2026, one of 10 people that filing names.
10 people named on the filing — 5 holding an executive role and 5 as directors only.
Named as of the 2026-09-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 10 people named on the filing — 5 holding an executive role and 5 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on BioStem Technologies, Inc.
- Source Check — verify Jason Matuszewski's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Jason Matuszewski for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist BioStem Technologies, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind BioStem Technologies, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.